# Implantation or Injectable Dosage Form New Animal Drugs; Penicillin G Benzathine and Penicillin G Procaine Sterile Suspension
> **Food and Drug Administration** · Final rule. · Published 2005-04-28 · Effective 2005-04-28 · 70 FR 21946
## Document
- **Document number:** 05-8510
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 70 FR 21946
- **CFR reference:** 21 CFR 522
- **Publication date:** 2005-04-28
- **Effective date:** 2005-04-28
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Cross Vetpharm Group Ltd. The supplemental NADA provides for the addition of statements to labeling of an injectable penicillin suspension warning against the use of this product in calves to be processed for veal. FDA is also amending the regulations to correctly identify approved indications for use for several penicillin products. This action is being taken to improve the accuracy of the regulations.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2005/04/28/05-8510/implantation-or-injectable-dosage-form-new-animal-drugs-penicillin-g-benzathine-and-penicillin-g)
---
*AI Analytics · CC0 1.0*